Aligos Therapeutics, Inc. (ALGS) Operating cash flow 2019–2025
Aligos Therapeutics, Inc. (ALGS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$82.5MFY2025 · since FY2019: -$46.8M → -$82.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$82.5M | -2.2% |
| FY2024 | -$80.7M | -2.2% |
| FY2023 | -$79.0M | +0.5% |
| FY2022 | -$79.4M | +31.4% |
| FY2021 | -$115.7M | -55.7% |
| FY2020 | -$74.3M | -58.8% |
| FY2019 | -$46.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice